sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
»ùÒòÐÞÊμ׼õ֢СÊóÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > »ùÒòÐÞÊμ׼õ֢СÊóÄ£×Ó

ǰÑÔ

¼××´ÏÙ¹¦Ð§¼õÍËÖ¢(hypothyroidism)¼ò³Æ¼×¼õÖ¢ £¬ÊÇÓÉÓÚÖÖÖÖÔµ¹ÊÔ­ÓÉÒýÆð¼××´ÏÙ¼¤Ëغϡ¢ÉøÍ¸»ò¼××´ÏÙËØÉúÎïѧЧӦȱ·¦ £¬µ¼Ö»úÌå´úлÔ˶¯ºÍ½»¸ÐÉñ¾­ÐË·ÜÐÔϽµµÄÁÙ´²×ÛºÏÕ÷¡£Æä²¡ÀíÌØÕ÷ÊÇð¤¶àÌǵÈÔÚ×éÖ¯ºÍƤ·ôÖÐȺ¼¯ £¬ÑÏÖØÕßÌåÏÖΪð¤ÒºÐÔË®Öס£Å®ÐԽ϶à¼û¡£±¬·¢ÔÚÌ¥¶ù»òÐÂÉú¶ùµÄ¼×¼õÖ¢³ÆÎª´ôС²¡£¨¿ËÍ¡²¡£© £¬ÌåÏÖΪÖÇÁ¦µÍϺͷ¢Óý»ºÂý¡£

ÒýÆð¼×¼õÖ¢µÄ²¡ÒòÖ÷ÒªÓУºÖÖÖÖ¼××´ÏÙÑ×Ôì³É¼××´ÏÙ×éÖ¯µÄËðÉËºÍÆÆË𠣬ÒýÆðÁ˼׼õÖ¢£»³¤Ê±¼äȱµâ £¬Ê¹ºÏ³É¼××´ÏÙ¼¤ËصÄÖÊÁÏȱ·¦ £¬Òò¶ø¼××´ÏÙ¼¤ËصĺϳÉïÔÌ­£»¼××´ÏÙÊÖÊõʱ £¬½«¼××´ÏÙËùÓÐÇгý £¬»òÇгýµÄ¼××´ÏÙ×éÖ¯¹ý¶à £¬Òà¿ÉÒýÆð¼×¼õÖ¢£»·ÅÉäÐÔ131µâÖÎÁÆÊ± £¬131µâÓÃÁ¿¹ý´ó £¬Ê¹¼××´ÏÙ×éÖ¯ÆÆËð¹ý¶à £¬Òà¿É·ºÆð¼×¼õÖ¢£»ÓÐЩҩÎï¿ÉÒÔÒÖÖÆ¼××´ÏÙ¼¤ËصÄÌìÉú £¬Òò¶øÒýÆð¼×¼õÖ¢£»ÏÂÇðÄÔ£­´¹Ì岡±äʱ £¬Òò´Ù¼××´ÏÙ¼¤ËØÈ±·¦ £¬Ê¹¼××´ÏÙÌìÉú¼××´ÏÙ¼¤ËصĹ¦Ð§¼õµÍ¡£

Õë¶ÔÉÏÊö²¡Òò £¬¼×¼õÖ¢µÄ¶¯ÎïÄ£×ÓÓÐÓÕ·¢ÐÔ¶¯ÎïÄ£×Ó¡¢×Ô¾õÐÔ¶¯ÎïÄ£×ӺͻùÒòÐÞÊζ¯ÎïÄ£×Ó3Àà¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

¼××´ÏÙÌØÒìÐÔת¼Òò×Ó1(thyroid-specific transcription factor 1,TTF-1)ÓֳƼ××´ÏÙÌØÒìÐÔÔöÇ¿×ÓÍŽáÂѰ×(thyroid-specific enhancer-binding protein) £¬ÊÇת¼Òò×Ó¼Ò×åµÄÒ»¸ö³ÉÔ± £¬º¬ÓÐͬԴ¿òÓò¡£TTF-1ÔÚÅßÌ¥Æ÷¹ÙÐγÉÖм«ÆäÖ÷Òª £¬TTF-1»ùÒòÇóý½«µ¼ÖÂËÀÌ¥ £¬È±·¦¼××´Ïٺʹ¹ÌåÏÙ £¬·ÎºÍǰÄÔ¸¹²à¡¢»ù²¿È±ÏÝ £¬ÒÔ¼°²Ò°×Çò½á¹¹·¢Óý²»È«¡£

TTF-1»ùÒò±í´ï¼××´ÏÙ¹ýÑõ»¯Îïø¡¢¼××´ÏÙÇòÂѰ׺ʹټ××´ÏÙ¼¤ËØÊÜÌå3ÖÖÂѰס£ÕâÈýÖÖÂѰ׶Լ××´ÏÙËØµÄÉúÎïºÏ³ÉÖÁ¹ØÖ÷Òª¡£TTF-1»ùÒòÇóýµ¼ÖÂÏÈÌìÐÔ¼×¼õÖ¢¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

º¬ÓÐTTF-1»ùÒòµÄÕû¸ö±àÂëÇøºÍ3’¶Ë·Ç±àÂëÇøÐòÁй²5.9kbÓÃÀ´¹¹½¨´ò°ÐÔØÌå £¬Õýɸѡneor»ùÒò²åÈëµ½TTF-1»ùÒòµÄµÚ2ÍâÏÔ×ÓÖÐÐÄ £¬µ¼ÖÂͬԴÓòÐòÁеĵÚ1¸öÂÝÐýÆÆËð£»tk±í´ïºÐÓÃÓÚ·ÇÍ¬Ô´ÖØ×éµÄ¸ºÉ¸Ñ¡¡£É¸Ñ¡³öµÄ¶¨µãÕûºÏESϸ°û¿Ë¡ÏÔ΢עÉäµ½C57BL/6СÊóÅßÄÚ £¬±¬·¢Ç¶ºÏÌåСÊó¡£5/9µÄÐÛÐÔǶºÏÌåСÊó½«ESϸ°û»ùÒò×é´«¸øÁË×ÓÅ®¡£

¡¾Ä£×ÓÌØµã¡¿£º

ÔÓºÏ×ÓСÊó·¢ÓýÕý³£¡£´¿ºÏ×ÓСÊó³öÉúʱ¼´éæÃü £¬ÎÞ¼××´ÏÙ £¬µ«ÓÐÕý³£µÄ¼××´ÅÔÏÙ £¬È±·¦·ÎʵÖÊ £¬µ«¾ßÓлù±¾µÄÖ§Æø¹ÜÊ÷ £¬ÐØÄ¤Ç»ÉÏÆ¤Òì³£ £¬´¿ºÏ×ÓСÊóÄÔÄÚÆÕ±éȱÏÝ £¬ÌØÊâÊÇǰÄԵĸ¹²¿¡£Õû¸ö´¹Ì壨°üÀ¨Ç°Ò¶¡¢ÖÐÒ¶ºÍºóÒ¶£©È±·¦¡£Ô­Î»ÔÓ½»ÏÔʾTTF-1»ùÒòÔÚÅßÌ¥±¬·¢ÔçÆÚÔÚÕý³£¼××´ÏÙ¡¢·ÎÖ§Æø¹ÜÉÏÆ¤ºÍǰÄÔµÄÌØÒìÐÔÇøÓò±í´ï¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

´ËÄ£×Ó¿ÉÓÃÓÚÏÈÌìÐÔ¼×¼õ֢̥×з¢ÓýµÄÑо¿¡£ÓÉÓÚTTF-1ÔÚÅßÌ¥¶àÖÖÆ÷¹ÙÐγÉÖÐÆð×÷Óà £¬TTF-1»ùÒòÇóý²»µ«Ó°Ïì¼××´ÏÙËØµÄºÏ³É £¬Ò²Ó°ÏìÆäËûÆ÷¹Ù£¨ÈçÄÔ¡¢´¹Ìå¡¢·ÎÔàµÈ£©µÄÐÎ³É £¬²¢²»ÍêÈ«ÇкÏÏÈÌìÐÔ¼×¼õÖ¢µÄÁÙ´²ÌåÏÖ £¬ÓôËÄ£×ÓÔÚÆÊÎöʵÑéЧ¹ûʱӦ¼ÓÒÔ×¢ÖØ¡£

  

²Î¿¼ÎÄÏ×£º

1.ÀîÀö £¬Àîºìε £¬ËÎÑÒ £¬µÈ£®¶ÌÆÚµâÌúÍŽáȱ·¦´óÊó¶¯ÎïÄ£×ӵĽ¨É裮ÇéÐÎÓ뿵½¡ÔÓÖ¾ £¬2010, 27 (7):565-567

2.Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid g.land require Pax8 gene function. Nat Genet, 1998, 19(1):87-90

3.Amendola E, De Luca P, Macchia PE, et al. A mouse model demonstrates a multigenic origin of congenital hypothyroidism. Endocrinology, 2005, 146 (12): 5038- 5047

4.Hetzel BS, Mano MT. A review of e.xperimental studies of iodine deficiency during fetal development. J Nutr, 1989, 119(2): 145-151

5.Eftekhari MH,Keshavarz SA,Jalali M,et al. The relationship between iron status and thyroid hormone concentration in iron-deficient adolescent Iranian girl . Asia Pac J Clin Nutr, 2006, 15 (1):50-55

6.Argumedo GS,Sanz CR,Olgu í n HJ. Experimental models of developmental hypothyroidism. Horm Metab Res,2012,44 (2):79-85

7.Johnson KR,Marden CC, Ward-Bailey P,et al. Congenital hypothyroidism,dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol Endocrinol, 2007, 21 (7):1593-1602

8.Kimura S, Hara Y, Pineau T, el al. The T/ebp null mouse: thyrojd-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev, 1996, 10(1):60-69

9.Usenko V, Lepekbin E,Lyzoguhov V,el al. The influence of low doses 131 I-induced maternal hypothyroidism on the development of rat embryos. Exp Toxicol Patbol, 1999, 51 (3):223-227

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > »ùÒòÐÞÊμ׼õ֢СÊóÄ£×Ó
»ùÒòÐÞÊμ׼õ֢СÊóÄ£×Ó

ǰÑÔ

¼××´ÏÙ¹¦Ð§¼õÍËÖ¢(hypothyroidism)¼ò³Æ¼×¼õÖ¢ £¬ÊÇÓÉÓÚÖÖÖÖÔµ¹ÊÔ­ÓÉÒýÆð¼××´ÏÙ¼¤Ëغϡ¢ÉøÍ¸»ò¼××´ÏÙËØÉúÎïѧЧӦȱ·¦ £¬µ¼Ö»úÌå´úлÔ˶¯ºÍ½»¸ÐÉñ¾­ÐË·ÜÐÔϽµµÄÁÙ´²×ÛºÏÕ÷¡£Æä²¡ÀíÌØÕ÷ÊÇð¤¶àÌǵÈÔÚ×éÖ¯ºÍƤ·ôÖÐȺ¼¯ £¬ÑÏÖØÕßÌåÏÖΪð¤ÒºÐÔË®Öס£Å®ÐԽ϶à¼û¡£±¬·¢ÔÚÌ¥¶ù»òÐÂÉú¶ùµÄ¼×¼õÖ¢³ÆÎª´ôС²¡£¨¿ËÍ¡²¡£© £¬ÌåÏÖΪÖÇÁ¦µÍϺͷ¢Óý»ºÂý¡£

ÒýÆð¼×¼õÖ¢µÄ²¡ÒòÖ÷ÒªÓУºÖÖÖÖ¼××´ÏÙÑ×Ôì³É¼××´ÏÙ×éÖ¯µÄËðÉËºÍÆÆË𠣬ÒýÆðÁ˼׼õÖ¢£»³¤Ê±¼äȱµâ £¬Ê¹ºÏ³É¼××´ÏÙ¼¤ËصÄÖÊÁÏȱ·¦ £¬Òò¶ø¼××´ÏÙ¼¤ËصĺϳÉïÔÌ­£»¼××´ÏÙÊÖÊõʱ £¬½«¼××´ÏÙËùÓÐÇгý £¬»òÇгýµÄ¼××´ÏÙ×éÖ¯¹ý¶à £¬Òà¿ÉÒýÆð¼×¼õÖ¢£»·ÅÉäÐÔ131µâÖÎÁÆÊ± £¬131µâÓÃÁ¿¹ý´ó £¬Ê¹¼××´ÏÙ×éÖ¯ÆÆËð¹ý¶à £¬Òà¿É·ºÆð¼×¼õÖ¢£»ÓÐЩҩÎï¿ÉÒÔÒÖÖÆ¼××´ÏÙ¼¤ËصÄÌìÉú £¬Òò¶øÒýÆð¼×¼õÖ¢£»ÏÂÇðÄÔ£­´¹Ì岡±äʱ £¬Òò´Ù¼××´ÏÙ¼¤ËØÈ±·¦ £¬Ê¹¼××´ÏÙÌìÉú¼××´ÏÙ¼¤ËصĹ¦Ð§¼õµÍ¡£

Õë¶ÔÉÏÊö²¡Òò £¬¼×¼õÖ¢µÄ¶¯ÎïÄ£×ÓÓÐÓÕ·¢ÐÔ¶¯ÎïÄ£×Ó¡¢×Ô¾õÐÔ¶¯ÎïÄ£×ӺͻùÒòÐÞÊζ¯ÎïÄ£×Ó3Àà¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

¼××´ÏÙÌØÒìÐÔת¼Òò×Ó1(thyroid-specific transcription factor 1,TTF-1)ÓֳƼ××´ÏÙÌØÒìÐÔÔöÇ¿×ÓÍŽáÂѰ×(thyroid-specific enhancer-binding protein) £¬ÊÇת¼Òò×Ó¼Ò×åµÄÒ»¸ö³ÉÔ± £¬º¬ÓÐͬԴ¿òÓò¡£TTF-1ÔÚÅßÌ¥Æ÷¹ÙÐγÉÖм«ÆäÖ÷Òª £¬TTF-1»ùÒòÇóý½«µ¼ÖÂËÀÌ¥ £¬È±·¦¼××´Ïٺʹ¹ÌåÏÙ £¬·ÎºÍǰÄÔ¸¹²à¡¢»ù²¿È±ÏÝ £¬ÒÔ¼°²Ò°×Çò½á¹¹·¢Óý²»È«¡£

TTF-1»ùÒò±í´ï¼××´ÏÙ¹ýÑõ»¯Îïø¡¢¼××´ÏÙÇòÂѰ׺ʹټ××´ÏÙ¼¤ËØÊÜÌå3ÖÖÂѰס£ÕâÈýÖÖÂѰ׶Լ××´ÏÙËØµÄÉúÎïºÏ³ÉÖÁ¹ØÖ÷Òª¡£TTF-1»ùÒòÇóýµ¼ÖÂÏÈÌìÐÔ¼×¼õÖ¢¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

º¬ÓÐTTF-1»ùÒòµÄÕû¸ö±àÂëÇøºÍ3’¶Ë·Ç±àÂëÇøÐòÁй²5.9kbÓÃÀ´¹¹½¨´ò°ÐÔØÌå £¬Õýɸѡneor»ùÒò²åÈëµ½TTF-1»ùÒòµÄµÚ2ÍâÏÔ×ÓÖÐÐÄ £¬µ¼ÖÂͬԴÓòÐòÁеĵÚ1¸öÂÝÐýÆÆËð£»tk±í´ïºÐÓÃÓÚ·ÇÍ¬Ô´ÖØ×éµÄ¸ºÉ¸Ñ¡¡£É¸Ñ¡³öµÄ¶¨µãÕûºÏESϸ°û¿Ë¡ÏÔ΢עÉäµ½C57BL/6СÊóÅßÄÚ £¬±¬·¢Ç¶ºÏÌåСÊó¡£5/9µÄÐÛÐÔǶºÏÌåСÊó½«ESϸ°û»ùÒò×é´«¸øÁË×ÓÅ®¡£

¡¾Ä£×ÓÌØµã¡¿£º

ÔÓºÏ×ÓСÊó·¢ÓýÕý³£¡£´¿ºÏ×ÓСÊó³öÉúʱ¼´éæÃü £¬ÎÞ¼××´ÏÙ £¬µ«ÓÐÕý³£µÄ¼××´ÅÔÏÙ £¬È±·¦·ÎʵÖÊ £¬µ«¾ßÓлù±¾µÄÖ§Æø¹ÜÊ÷ £¬ÐØÄ¤Ç»ÉÏÆ¤Òì³£ £¬´¿ºÏ×ÓСÊóÄÔÄÚÆÕ±éȱÏÝ £¬ÌØÊâÊÇǰÄԵĸ¹²¿¡£Õû¸ö´¹Ì壨°üÀ¨Ç°Ò¶¡¢ÖÐÒ¶ºÍºóÒ¶£©È±·¦¡£Ô­Î»ÔÓ½»ÏÔʾTTF-1»ùÒòÔÚÅßÌ¥±¬·¢ÔçÆÚÔÚÕý³£¼××´ÏÙ¡¢·ÎÖ§Æø¹ÜÉÏÆ¤ºÍǰÄÔµÄÌØÒìÐÔÇøÓò±í´ï¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

´ËÄ£×Ó¿ÉÓÃÓÚÏÈÌìÐÔ¼×¼õ֢̥×з¢ÓýµÄÑо¿¡£ÓÉÓÚTTF-1ÔÚÅßÌ¥¶àÖÖÆ÷¹ÙÐγÉÖÐÆð×÷Óà £¬TTF-1»ùÒòÇóý²»µ«Ó°Ïì¼××´ÏÙËØµÄºÏ³É £¬Ò²Ó°ÏìÆäËûÆ÷¹Ù£¨ÈçÄÔ¡¢´¹Ìå¡¢·ÎÔàµÈ£©µÄÐÎ³É £¬²¢²»ÍêÈ«ÇкÏÏÈÌìÐÔ¼×¼õÖ¢µÄÁÙ´²ÌåÏÖ £¬ÓôËÄ£×ÓÔÚÆÊÎöʵÑéЧ¹ûʱӦ¼ÓÒÔ×¢ÖØ¡£

  

²Î¿¼ÎÄÏ×£º

1.ÀîÀö £¬Àîºìε £¬ËÎÑÒ £¬µÈ£®¶ÌÆÚµâÌúÍŽáȱ·¦´óÊó¶¯ÎïÄ£×ӵĽ¨É裮ÇéÐÎÓ뿵½¡ÔÓÖ¾ £¬2010, 27 (7):565-567

2.Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid g.land require Pax8 gene function. Nat Genet, 1998, 19(1):87-90

3.Amendola E, De Luca P, Macchia PE, et al. A mouse model demonstrates a multigenic origin of congenital hypothyroidism. Endocrinology, 2005, 146 (12): 5038- 5047

4.Hetzel BS, Mano MT. A review of e.xperimental studies of iodine deficiency during fetal development. J Nutr, 1989, 119(2): 145-151

5.Eftekhari MH,Keshavarz SA,Jalali M,et al. The relationship between iron status and thyroid hormone concentration in iron-deficient adolescent Iranian girl . Asia Pac J Clin Nutr, 2006, 15 (1):50-55

6.Argumedo GS,Sanz CR,Olgu í n HJ. Experimental models of developmental hypothyroidism. Horm Metab Res,2012,44 (2):79-85

7.Johnson KR,Marden CC, Ward-Bailey P,et al. Congenital hypothyroidism,dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol Endocrinol, 2007, 21 (7):1593-1602

8.Kimura S, Hara Y, Pineau T, el al. The T/ebp null mouse: thyrojd-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev, 1996, 10(1):60-69

9.Usenko V, Lepekbin E,Lyzoguhov V,el al. The influence of low doses 131 I-induced maternal hypothyroidism on the development of rat embryos. Exp Toxicol Patbol, 1999, 51 (3):223-227

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿